Bild zu Biopharm


2016 30 years Biopharm GmbH.

2015 Biopharm GmbH moved from Heidelberg to Eppelheim.

2014 Clear effects of Biopharm's growth factor and it's mutants shown in the following areas: Parkinson's disease, Erectile Dysfunction and peripheral nervous system. Proof of Concept (POC) for all indications succesfully achieved.

2013 Cooperation with Merck Serono in research directed toward the molecular engineering of a biologic compound for the treatment of osteoarthritis.

2012 New project in the field of osteoporosis in cooperation with Jena University and funded by the German Ministry of Education and Research

2011 Submission of IDE (Phase III) for MD05-P by Medtronic, Inc. (Scil Technology GmbH)

2011 Exclusive Research Cooperation with Prof. Dr. Dr. Detlef Schuppan (Harvard University/Mainz University) in Personalized Medicine

2011 Exclusive Research Cooperation with Freudenberg (Weinheim) for Advanced Wound Care

2010 Expansion of Growth Factor Platform Technology

2008 International sub-license for rhGDF-5 in oral, maxillary and facial surgery to Medtronic, Inc.

2006 Modernization of the cell culture laboratory, 40 employees at two sites

2004 Start of the multicenter clinical trial for the indication "Spinal Fusion" in the USA

2002 International license for rhGDF-5 in orthopedics to DePuy Spine, Johnson & Johnson

2001 International license for rhGDF-5 in oral, maxillary and facial surgery to Scil Technology GmbH

1999 Occupation of second building with more than 1500 qm of modern laboratory and office space in Eppelheim near Heidelberg

1997 35 employees, start of work on the development of biogenerics and bioassays for products for important therapeutic indications

1994 First international cooperation with a large industrial partner for the development of rhGDF-5

1993 First GLP certification

1992 International patents for rhGDF-5 and MP121

1989 15 employees, well established contract analysis and internal research

1986 Biopharm founded by Michael Paulista in Heidelberg